Arcturus Therapeutics Holdings, Inc. (ARCT)
7.02
+0.20
(+2.93%)
USD |
NASDAQ |
May 21, 16:00
7.00
-0.02
(-0.28%)
After-Hours: 04:19
Arcturus Therapeutics Holdings Research and Development Expense (TTM) : 87.94M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Twist Bioscience Corp. | 71.89M |
| Denali Therapeutics, Inc. | 406.40M |
| Agenus, Inc. | 69.64M |
| Curis, Inc. | 26.16M |
| LadRx Corp. | 0.7712M |